<p>Quantbot Technologies LP 在第三季度购买了 Axon Enterprise, Inc (NASDAQ:AXON - 免费报告) 的新股份，根据该公司最近向证券交易委员会提交的 13F 文件。该公司购买了 2,350 股生物技术公司的股票，价值约为 1,686,000 美元。</p>
<p>获取 <strong>Axon Enterprise</strong> 警报：</p>
<ul>
<li>Axon 在 SaaS 崩盘中被卷入——其收益表明这是一个错误</li>
</ul>
<p>其他机构投资者和对冲基金最近也调整了对该公司的持股。Handelsbanken Fonder AB 在第三季度将其在 Axon Enterprise 的持股增加了 9.0%。Handelsbanken Fonder AB 现在拥有 65,590 股生物技术公司的股票，价值 47,070,000 美元，此前在上个季度增持了 5,423 股。Andra AP fonden 在第三季度将其在 Axon Enterprise 的持股增加了 38.8%。Andra AP fonden 现在拥有 23,973 股生物技术公司的股票，价值 17,204,000 美元，此前在上个季度增持了 6,700 股。Artisan Partners Limited Partnership 在第三季度将其在 Axon Enterprise 的持股增加了 2,541.0%。Artisan Partners Limited Partnership 现在拥有 96,053 股生物技术公司的股票，价值 68,931,000 美元，此前在此期间增持了 99,988 股。Xponance Inc. 在第三季度将其在 Axon Enterprise 的持股增加了 0.8%。Xponance Inc. 现在拥有 17,958 股生物技术公司的股票，价值 12,887,000 美元，此前在上个季度增持了 147 股。最后，DNB Asset Management AS 在第三季度将其在 Axon Enterprise 的持股增加了 24.6%。DNB Asset Management AS 现在拥有 27,267 股生物技术公司的股票，价值 19,568,000 美元，此前在上个季度增持了 5,379 股。79.08% 的股票由机构投资者持有。</p>
<h2>Axon Enterprise 的内部活动</h2>
<p>在相关消息中，首席财务官 Brittany Bagley 于 12 月 11 日星期四出售了 2,000 股公司的股票。股票以平均价格 580.00 美元出售，总交易额为 1,160,000.00 美元。出售后，首席财务官持有 103,501 股公司股票，价值约 60,030,580 美元。这代表其持股减少了 1.90%。该交易在与 SEC 的法律文件中披露，可以通过此超链接访问。此外，首席会计官 Jennifer H. Mak 于 3 月 2 日星期一出售了 1,500 股公司的股票。股票以平均价格 573.45 美元出售，总价值为 860,175.00 美元。交易完成后，首席会计官持有 12,240 股公司的股票，价值约 7,019,028 美元。这代表其持股减少了 10.92%。该销售的 SEC 文件提供了更多信息。在过去的 90 天里，内部人士出售了价值 31,534,295 美元的 56,634 股公司股票。公司内部人士持有 4.40% 的公司股票。</p>
<h2>Axon Enterprise 股价下跌 1.6%</h2>
<ul>
<li>为什么 Axon 的 16% 激增标志着公共安全技术的新纪元</li>
</ul>
<p>NASDAQ:AXON 周四开盘价为 569.81 美元。该公司的速动比率为 2.29，流动比率为 2.53，债务与股本比率为 0.53。Axon Enterprise, Inc 的 12 个月最低价为 396.41 美元，12 个月最高价为 885.91 美元。该公司的市值为 458.1 亿美元，市盈率为 374.88，市盈增长比率为 12.36，贝塔系数为 1.46。该业务的 50 日移动平均价格为 536.69 美元，200 日移动平均价格为 620.70 美元。</p>
<p>Axon Enterprise (NASDAQ:AXON - 获取免费报告) 最近于 2 月 24 日星期二公布了其财报。这家生物技术公司报告本季度每股收益为 2.15 美元，超出市场共识预期的 1.60 美元，超出 0.55 美元。该季度的收入为 796.72 百万美元，而分析师预期为 755.29 百万美元。Axon Enterprise 的净利润率为 4.48%，股本回报率为 2.82%。该公司的收入同比增长 38.5%。在去年同期，该公司每股收益为 2.08 美元。整体而言，分析师预计 Axon Enterprise, Inc 在当前财政年度将发布 5.8 美元的每股收益。</p>
<h2>影响 Axon Enterprise 的关键故事</h2>
<ul>
<li>MarketBeat 周回顾 – 06/02 - 06/06</li>
</ul>
<p>以下是本周影响 Axon Enterprise 的关键新闻故事：</p>
<ul>
<li>积极情绪：二季度业绩超预期：Axon 报告了每股收益和收入的上升（强劲的年度经常性收入/订阅增长和预订在财报电话会议中得到了强调），强化了公司类似 SaaS 的经常性收入叙述，并支持未来的增长预期。财报电话会议亮点</li>
<li>积极情绪：分析师乐观：TD Cowen 和其他经纪公司在强劲的预订和年度经常性收入趋势后提高了目标价，并重申了买入/跑赢大盘的观点（TD Cowen 提高了其目标），为牛市案例提供了机构支持。强劲预订增长后提高目标价</li>
<li>中性情绪：投资者接触/可见性：管理层在摩根士丹利 TMT 会议上进行了演讲——这对投资者互动很有帮助，但会议记录中没有包含新的指引或会立即重新评估股票的惊喜。会议演讲记录</li>
<li>中性情绪：市场评论褒贬不一：财报后的报道赞扬了增长（Axon 911，年度经常性收入），但指出前瞻性倍数非常高，这意味着股票需要持续的执行来证明估值。Zacks 和其他汇总提到 Axon 是推荐的想法之一，但没有改变短期基本面。Zacks 投资想法</li>
<li>消极情绪：内部人士卖出：董事/内部人士 Isaiah Fields 出售了 2,000 股（约 535 美元的平均价格），减少了其持股——这样的销售可能被视为负面，并给情绪带来压力。SEC 文件 — Fields 出售</li>
<li>消极情绪：额外的内部人士出售：首席会计官 Jennifer H. Mak 以大约 573.45 美元的价格出售了 1,500 股，进一步表明内部人士正在减持。SEC 文件 — Mak 出售</li>
<li>消极情绪：综合报道（TipRanks，MarketBeat）指出在短时间内有多次内部人士出售，这可能加剧投资者对短期卖压的担忧，即使交易量不大。内部人士销售报道</li>
</ul>
<h2>分析师设定新的目标价</h2>
<p>几家研究公司对 AXON 发表了看法。Piper Sandler 将 Axon Enterprise 的目标价从 753.00 美元下调至 690.00 美元，并在 2 月 25 日的报告中对该股票给予了 “超配” 评级。华尔街 Zen 在 2 月 28 日的报告中将 Axon Enterprise 的评级从 “卖出” 上调至 “持有”。花旗在 2 月 25 日的研究报告中重申了对 Axon Enterprise 股票的 “买入” 评级。Needham &amp; Company LLC 在 2 月 20 日的研究报告中将 Axon Enterprise 股票的目标价从 870.00 美元下调至 600.00 美元，并对该股票给予了 “买入” 评级。最后，William Blair 在 2 月 3 日的研究报告中重申了对 Axon Enterprise 股票的 “跑赢大盘” 评级。十六位股票研究分析师对该股票给予了买入评级，三位给予了持有评级。根据 MarketBeat 的数据，Axon Enterprise 目前的共识评级为 “适度买入”，平均目标价为 762.93 美元。</p>
<p><strong>查看我们对 Axon Enterprise 的最新分析</strong></p>
<h2>Axon Enterprise 公司简介</h2>
<p>（免费报告）</p>
<p>Axon Enterprise, Inc 开发公共安全和执法机构的技术和武器系统，结合硬件、软件和云服务。公司的硬件产品组合包括电击武器（通常称为 TASER 设备）、佩戴式摄像头和车载摄像头系统。Axon 将这些设备与一套连接的产品和配件相结合，旨在捕获、存储和管理现场证据。</p>
<p>除了硬件，Axon 还运营一个基于订阅的软件平台，用于数字证据管理、证据审查和记录管理。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们更看好的股票，胜过 Axon Enterprise</li>
<li>华尔街害怕的黄金图表……</li>
<li>美国的 1776 再次发生</li>
<li>在 2026 年 5 月之前购买这只黄金股票</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
<li>用这 4 个简单步骤 “防止美联储影响” 你的银行账户</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVhPTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVhPTg"/></p>
<p><em>此即时新闻提醒是由叙事科学技术和 MarketBeat 的金融数据生成的，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Axon Enterprise 吗？</h2>
<p>在你考虑 Axon Enterprise 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Axon Enterprise 并不在名单上。</p>
<p>虽然 Axon Enterprise 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

GUNZ

AXUP

AXON

<p>Quantbot Technologies LP 在第三季度收购了 2,350 股 Axon Enterprise, Inc (NASDAQ:AXON)，价值约为 169 万美元，具体情况在其最近的 13F 文件中披露。其他机构投资者也增加了对 Axon 的持股，其中 Handelsbanken Fonder AB 和 Artisan Partners 的增持尤为显著。内部交易活动中，首席财务官 Brittany Bagley 出售了 2,000 股。Axon 的股票开盘价为 569.81 美元，市值为 458.1 亿美元，市盈率为 374.88。公司报告了强劲的收益，收入同比增长 38.5%，超出预期</p>

<p>Quantbot Technologies LP bought a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities &amp; Exchange Commission. The firm bought 2,350 shares of the biotechnology company's stock, valued at approximately $1,686,000.</p>
<div class="lb-trans"><p>Quantbot Technologies LP 在第三季度购买了 Axon Enterprise, Inc (NASDAQ:AXON - 免费报告) 的新股份，根据该公司最近向证券交易委员会提交的 13F 文件。该公司购买了 2,350 股生物技术公司的股票，价值约为 1,686,000 美元。</p>
</div><p>Get <strong>Axon Enterprise</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Axon Enterprise</strong> 警报：</p>
</div><ul>
<li>Axon Got Caught in the SaaS Crash—Its Earnings Say That Was a Mistake</li>
</ul>
<div class="lb-trans"><ul>
<li>Axon 在 SaaS 崩盘中被卷入——其收益表明这是一个错误</li>
</ul>
</div><p>Other institutional investors and hedge funds also recently modified their holdings of the company. Handelsbanken Fonder AB boosted its stake in Axon Enterprise by 9.0% during the 3rd quarter. Handelsbanken Fonder AB now owns 65,590 shares of the biotechnology company's stock worth $47,070,000 after acquiring an additional 5,423 shares during the last quarter. Andra AP fonden boosted its position in shares of Axon Enterprise by 38.8% during the third quarter. Andra AP fonden now owns 23,973 shares of the biotechnology company's stock worth $17,204,000 after purchasing an additional 6,700 shares in the last quarter. Artisan Partners Limited Partnership grew its holdings in shares of Axon Enterprise by 2,541.0% in the 3rd quarter. Artisan Partners Limited Partnership now owns 96,053 shares of the biotechnology company's stock valued at $68,931,000 after buying an additional 99,988 shares during the period. Xponance Inc. increased its position in shares of Axon Enterprise by 0.8% in the 3rd quarter. Xponance Inc. now owns 17,958 shares of the biotechnology company's stock valued at $12,887,000 after buying an additional 147 shares in the last quarter. Finally, DNB Asset Management AS increased its position in shares of Axon Enterprise by 24.6% in the 3rd quarter. DNB Asset Management AS now owns 27,267 shares of the biotechnology company's stock valued at $19,568,000 after buying an additional 5,379 shares in the last quarter. 79.08% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>其他机构投资者和对冲基金最近也调整了对该公司的持股。Handelsbanken Fonder AB 在第三季度将其在 Axon Enterprise 的持股增加了 9.0%。Handelsbanken Fonder AB 现在拥有 65,590 股生物技术公司的股票，价值 47,070,000 美元，此前在上个季度增持了 5,423 股。Andra AP fonden 在第三季度将其在 Axon Enterprise 的持股增加了 38.8%。Andra AP fonden 现在拥有 23,973 股生物技术公司的股票，价值 17,204,000 美元，此前在上个季度增持了 6,700 股。Artisan Partners Limited Partnership 在第三季度将其在 Axon Enterprise 的持股增加了 2,541.0%。Artisan Partners Limited Partnership 现在拥有 96,053 股生物技术公司的股票，价值 68,931,000 美元，此前在此期间增持了 99,988 股。Xponance Inc. 在第三季度将其在 Axon Enterprise 的持股增加了 0.8%。Xponance Inc. 现在拥有 17,958 股生物技术公司的股票，价值 12,887,000 美元，此前在上个季度增持了 147 股。最后，DNB Asset Management AS 在第三季度将其在 Axon Enterprise 的持股增加了 24.6%。DNB Asset Management AS 现在拥有 27,267 股生物技术公司的股票，价值 19,568,000 美元，此前在上个季度增持了 5,379 股。79.08% 的股票由机构投资者持有。</p>
</div><h2>Insider Activity at Axon Enterprise</h2>
<div class="lb-trans"><h2>Axon Enterprise 的内部活动</h2>
</div><p>In related news, CFO Brittany Bagley sold 2,000 shares of the company's stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $580.00, for a total transaction of $1,160,000.00. Following the sale, the chief financial officer owned 103,501 shares in the company, valued at approximately $60,030,580. This represents a 1.90% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CAO Jennifer H. Mak sold 1,500 shares of the firm's stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $573.45, for a total value of $860,175.00. Following the completion of the transaction, the chief accounting officer owned 12,240 shares of the company's stock, valued at approximately $7,019,028. This represents a 10.92% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 56,634 shares of company stock worth $31,534,295. Corporate insiders own 4.40% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，首席财务官 Brittany Bagley 于 12 月 11 日星期四出售了 2,000 股公司的股票。股票以平均价格 580.00 美元出售，总交易额为 1,160,000.00 美元。出售后，首席财务官持有 103,501 股公司股票，价值约 60,030,580 美元。这代表其持股减少了 1.90%。该交易在与 SEC 的法律文件中披露，可以通过此超链接访问。此外，首席会计官 Jennifer H. Mak 于 3 月 2 日星期一出售了 1,500 股公司的股票。股票以平均价格 573.45 美元出售，总价值为 860,175.00 美元。交易完成后，首席会计官持有 12,240 股公司的股票，价值约 7,019,028 美元。这代表其持股减少了 10.92%。该销售的 SEC 文件提供了更多信息。在过去的 90 天里，内部人士出售了价值 31,534,295 美元的 56,634 股公司股票。公司内部人士持有 4.40% 的公司股票。</p>
</div><h2>Axon Enterprise Trading Down 1.6%</h2>
<div class="lb-trans"><h2>Axon Enterprise 股价下跌 1.6%</h2>
</div><ul>
<li>Why Axon's 16% Surge Signals a New Era in Public Safety Tech</li>
</ul>
<div class="lb-trans"><ul>
<li>为什么 Axon 的 16% 激增标志着公共安全技术的新纪元</li>
</ul>
</div><p>NASDAQ:AXON opened at $569.81 on Thursday. The company has a quick ratio of 2.29, a current ratio of 2.53 and a debt-to-equity ratio of 0.53. Axon Enterprise, Inc has a twelve month low of $396.41 and a twelve month high of $885.91. The company has a market cap of $45.81 billion, a P/E ratio of 374.88, a price-to-earnings-growth ratio of 12.36 and a beta of 1.46. The business has a 50 day moving average price of $536.69 and a two-hundred day moving average price of $620.70.</p>
<div class="lb-trans"><p>NASDAQ:AXON 周四开盘价为 569.81 美元。该公司的速动比率为 2.29，流动比率为 2.53，债务与股本比率为 0.53。Axon Enterprise, Inc 的 12 个月最低价为 396.41 美元，12 个月最高价为 885.91 美元。该公司的市值为 458.1 亿美元，市盈率为 374.88，市盈增长比率为 12.36，贝塔系数为 1.46。该业务的 50 日移动平均价格为 536.69 美元，200 日移动平均价格为 620.70 美元。</p>
</div><p>Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 EPS for the quarter, topping the consensus estimate of $1.60 by $0.55. The business had revenue of $796.72 million during the quarter, compared to analysts' expectations of $755.29 million. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. The firm's revenue was up 38.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.08 earnings per share. As a group, analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Axon Enterprise (NASDAQ:AXON - 获取免费报告) 最近于 2 月 24 日星期二公布了其财报。这家生物技术公司报告本季度每股收益为 2.15 美元，超出市场共识预期的 1.60 美元，超出 0.55 美元。该季度的收入为 796.72 百万美元，而分析师预期为 755.29 百万美元。Axon Enterprise 的净利润率为 4.48%，股本回报率为 2.82%。该公司的收入同比增长 38.5%。在去年同期，该公司每股收益为 2.08 美元。整体而言，分析师预计 Axon Enterprise, Inc 在当前财政年度将发布 5.8 美元的每股收益。</p>
</div><h2>Key Stories Impacting Axon Enterprise</h2>
<div class="lb-trans"><h2>影响 Axon Enterprise 的关键故事</h2>
</div><ul>
<li>MarketBeat Week in Review – 06/02 - 06/06</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 06/02 - 06/06</li>
</ul>
</div><p>Here are the key news stories impacting Axon Enterprise this week:</p>
<div class="lb-trans"><p>以下是本周影响 Axon Enterprise 的关键新闻故事：</p>
</div><ul>
<li>Positive Sentiment: February quarter beat: Axon reported upside to EPS and revenue (strong ARR/subscription growth and bookings highlighted on the earnings call), reinforcing the company's SaaS-like recurring revenue narrative and supporting future growth expectations. Earnings Call Highlights</li>
<li>Positive Sentiment: Analyst bullishness: TD Cowen and other brokers have raised price targets and reiterated buy/outperform views after strong bookings and ARR trends (TD Cowen raised its target), giving institutional support to the bull case. Price Target Raised After Strong Bookings Growth</li>
<li>Neutral Sentiment: Investor outreach/visibility: Management presented at the Morgan Stanley TMT conference — useful for investor engagement but the transcript did not contain new guidance or surprises that would immediately re-rate the stock. Conference Presentation Transcript</li>
<li>Neutral Sentiment: Market commentary is mixed: post-earnings coverage praises growth (Axon 911, ARR) but flags a very rich forward multiple, meaning the stock needs continued execution to justify valuation. Zacks and other roundups mention Axon among featured ideas but do not change near-term fundamentals. Zacks Investment Ideas</li>
<li>Negative Sentiment: Insider selling: Director/insider Isaiah Fields sold 2,000 shares (~$535 avg), trimming his stake — such sales can be perceived negatively and add pressure to sentiment. SEC Filing — Fields Sale</li>
<li>Negative Sentiment: Additional insider sale: CAO Jennifer H. Mak sold 1,500 shares at roughly $573.45, further signaling insiders taking chips off the table. SEC Filing — Mak Sale</li>
<li>Negative Sentiment: Aggregated coverage (TipRanks, MarketBeat) notes multiple insider sales in a short window, which can amplify investor concern about near-term selling pressure even if trades are modest. Insider Sales Coverage</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：二季度业绩超预期：Axon 报告了每股收益和收入的上升（强劲的年度经常性收入/订阅增长和预订在财报电话会议中得到了强调），强化了公司类似 SaaS 的经常性收入叙述，并支持未来的增长预期。财报电话会议亮点</li>
<li>积极情绪：分析师乐观：TD Cowen 和其他经纪公司在强劲的预订和年度经常性收入趋势后提高了目标价，并重申了买入/跑赢大盘的观点（TD Cowen 提高了其目标），为牛市案例提供了机构支持。强劲预订增长后提高目标价</li>
<li>中性情绪：投资者接触/可见性：管理层在摩根士丹利 TMT 会议上进行了演讲——这对投资者互动很有帮助，但会议记录中没有包含新的指引或会立即重新评估股票的惊喜。会议演讲记录</li>
<li>中性情绪：市场评论褒贬不一：财报后的报道赞扬了增长（Axon 911，年度经常性收入），但指出前瞻性倍数非常高，这意味着股票需要持续的执行来证明估值。Zacks 和其他汇总提到 Axon 是推荐的想法之一，但没有改变短期基本面。Zacks 投资想法</li>
<li>消极情绪：内部人士卖出：董事/内部人士 Isaiah Fields 出售了 2,000 股（约 535 美元的平均价格），减少了其持股——这样的销售可能被视为负面，并给情绪带来压力。SEC 文件 — Fields 出售</li>
<li>消极情绪：额外的内部人士出售：首席会计官 Jennifer H. Mak 以大约 573.45 美元的价格出售了 1,500 股，进一步表明内部人士正在减持。SEC 文件 — Mak 出售</li>
<li>消极情绪：综合报道（TipRanks，MarketBeat）指出在短时间内有多次内部人士出售，这可能加剧投资者对短期卖压的担忧，即使交易量不大。内部人士销售报道</li>
</ul>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新的目标价</h2>
</div><p>Several research firms have weighed in on AXON. Piper Sandler reduced their target price on Axon Enterprise from $753.00 to $690.00 and set an &#34;overweight&#34; rating on the stock in a report on Wednesday, February 25th. Wall Street Zen upgraded Axon Enterprise from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a report on Saturday, February 28th. Citigroup reissued a &#34;buy&#34; rating on shares of Axon Enterprise in a research note on Wednesday, February 25th. Needham &amp; Company LLC cut their price target on shares of Axon Enterprise from $870.00 to $600.00 and set a &#34;buy&#34; rating on the stock in a research note on Friday, February 20th. Finally, William Blair reissued an &#34;outperform&#34; rating on shares of Axon Enterprise in a research report on Tuesday, February 3rd. Sixteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Axon Enterprise presently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $762.93.</p>
<div class="lb-trans"><p>几家研究公司对 AXON 发表了看法。Piper Sandler 将 Axon Enterprise 的目标价从 753.00 美元下调至 690.00 美元，并在 2 月 25 日的报告中对该股票给予了 “超配” 评级。华尔街 Zen 在 2 月 28 日的报告中将 Axon Enterprise 的评级从 “卖出” 上调至 “持有”。花旗在 2 月 25 日的研究报告中重申了对 Axon Enterprise 股票的 “买入” 评级。Needham &amp; Company LLC 在 2 月 20 日的研究报告中将 Axon Enterprise 股票的目标价从 870.00 美元下调至 600.00 美元，并对该股票给予了 “买入” 评级。最后，William Blair 在 2 月 3 日的研究报告中重申了对 Axon Enterprise 股票的 “跑赢大盘” 评级。十六位股票研究分析师对该股票给予了买入评级，三位给予了持有评级。根据 MarketBeat 的数据，Axon Enterprise 目前的共识评级为 “适度买入”，平均目标价为 762.93 美元。</p>
</div><p><strong>Check Out Our Latest Analysis on Axon Enterprise</strong></p>
<div class="lb-trans"><p><strong>查看我们对 Axon Enterprise 的最新分析</strong></p>
</div><h2>Axon Enterprise Company Profile</h2>
<div class="lb-trans"><h2>Axon Enterprise 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.</p>
<div class="lb-trans"><p>Axon Enterprise, Inc 开发公共安全和执法机构的技术和武器系统，结合硬件、软件和云服务。公司的硬件产品组合包括电击武器（通常称为 TASER 设备）、佩戴式摄像头和车载摄像头系统。Axon 将这些设备与一套连接的产品和配件相结合，旨在捕获、存储和管理现场证据。</p>
</div><p>Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.</p>
<div class="lb-trans"><p>除了硬件，Axon 还运营一个基于订阅的软件平台，用于数字证据管理、证据审查和记录管理。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Axon Enterprise</li>
<li>The gold chart Wall Street is terrified of…</li>
<li>America’s 1776 happening again</li>
<li>Buy this Gold Stock Before May 2026</li>
<li>What a Former CIA Agent Knows About the Coming Collapse</li>
<li>“Fed Proof” Your Bank Account with THESE 4 Simple Steps</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Axon Enterprise</li>
<li>华尔街害怕的黄金图表……</li>
<li>美国的 1776 再次发生</li>
<li>在 2026 年 5 月之前购买这只黄金股票</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
<li>用这 4 个简单步骤 “防止美联储影响” 你的银行账户</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVhPTg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=AXON"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒是由叙事科学技术和 MarketBeat 的金融数据生成的，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Axon Enterprise Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Axon Enterprise 吗？</h2>
</div><p>Before you consider Axon Enterprise, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Axon Enterprise 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Axon Enterprise 并不在名单上。</p>
</div><p>While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Axon Enterprise 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Quantbot Technologies LP 收购了 Axon Enterprise, Inc 的新股 $AXON